FDA issues warnings on Three Popular Asthma drug labels

by Medindia Content Team on  May 16, 2006 at 3:35 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

FDA issues warnings on Three Popular Asthma drug labels
The U.S. Food and Drug Administration has updated the product labels for three widely known asthma drugs, which will now carry the warnings that the drugs may enhance the risk of suffering a severe asthma attack that could also turn fatal.

The drugs that now carry the updated product labels will be the powerful bronchodilator medicines Advair and Serevent, made by GlaxoSmithKline Plc and Foradil from Novartis AG .The FDA has further advised that these inhaled drugs should only be used after other types of inhaled drugs like corticosteroids, have failed to alleviate the asthma attack.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Childhood Asthma Drug Toxicity Asthma Signature Drug Toxicity Remedies for Seasonal Allergy Relief Allergy - Symptom Evaluation Wheezing Churg-Strauss Syndrome Tests for Asthma Stay Well This Winter 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive